Guardant Health (NASDAQ:GH) Given New $56.00 Price Target at The Goldman Sachs Group
Guardant Health (NASDAQ:GH – Get Free Report) had its target price boosted by research analysts at The Goldman Sachs Group from $49.00 to $56.00 in a research note issued to investors on Friday,Benzinga reports.
In a report released on February 19, Patty Kanada from Goldman Sachs maintained a Hold rating on Coty (COTY – Research Report), with a price ...
Barclays hit the dollar market in force with two trades in successive days this week to raise a total of $6.5bn.
Barclays Bank reveals a $131M stake in BlackRock’s Bitcoin ETF, marking further institutional adoption of digital assets.
In a report released today, Claudia Gaspari from Barclays maintained a Buy rating on Zurich Insurance Group (ZFSVF – Research Report), with a ...
Barclays and Marcus by Goldman Sachs both offer savings accounts with no minimum deposits and no monthly fees, and the APY is nearly identical. But Marcus’ same-day transfers may put it ahead of ...
Terreno Realty (NYSE:TRNO – Get Free Report) was upgraded by investment analysts at The Goldman Sachs Group from a “neutral” rating to a “buy” rating in a report issued on Friday, Marketbeat.com ...
Goldman Sachs cancelled a four-year-old policy to only take public companies that had two diverse board members, a ...
In this article, we are going to take a look at where The Goldman Sachs Group ... in stock and real estate values than in recent years. Barclays analyst Jason Goldberg highlighted these ...
Goldman Sachs analyst Ajay Patel maintained a Buy rating on Vestas Wind Systems (0NMK – Research Report) today and set a price target of ...
A potential Ukraine ceasefire and the associated easing in sanctions on Russia are unlikely to substantially increase ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback